-
4 weeks ago | 
academic.oup.com | A Coruna |Universitat de Barcelona |Juan Pablo |De Boer
ESC Guidelines provide best practice, evidence-based recommendations for diagnosing and treating patients with cardiovascular diseases. It is not always possible for best practices to be followed, however, particularly in low-resource settings. To address this issue, a set of guideline-related documents were created to identify key priorities for users in these settings.
-
1 month ago | 
eprints.gla.ac.uk | De Boer |Anna Maria |John J.V
Docherty, K. F. et al. (2025) Interleukin-6 in heart failure with reduced ejection fraction and the effect of dapagliflozin : an exploratory analysis of the dapagliflozin and prevention of adverse outcomes in heart failure trial. JACC: Heart Failure, (doi: 10.1016/j.jchf.2024.12.012) (PMID:40088234) (In Press)Text350177.pdf - Published Version Available under License Creative Commons Attribution.
-
Nov 30, 2024 | 
waldnet.nl | De Boer
Geplaatst: za 30 november 2024, 13.37Zwarte elektrische damesfiets, gestolen vrijdagavond tussen 18 en 21 uur, vanuit de fietsenrekken achter de HEMA Drachten. Heeft iemand de fiets gezien? Auto ramt gevel modezaak in Gorredijk Bij een verkeersongeval aan de Formanjestrjitte in Gorredijk is zaterdagmiddag een automobiliste gewond geraakt.
-
Oct 15, 2024 | 
karger.com | van Rees |De Boer |Amsterdam UMC |Koert F.D
Introduction: Clear guidelines for colorectal lung metastasis (LM) treatment are not available. This study aimed to provide insight into the treatment strategies and efficacy of local and systemic therapy in patients with LM eligible for (potentially) curative treatment. Methods: This was a retrospective study of patients with ≤5 LM discussed in two tertiary referral centers. Patient and tumor characteristics were compared between treatment groups.
-
Oct 13, 2024 | 
link.springer.com | De Boer
AbstractPatients with opioid use disorder (OUD), especially those treated with methadone, face significant challenges to placement in a skilled nursing facility (SNF). Efforts to address this via legal actions have not resulted in improved access. To understand regulatory and non-regulatory factors that impact SNF placement of patients with OUD treated with methadone. Observational qualitative study.
-
Oct 11, 2024 | 
eprints.gla.ac.uk | Buendía López |De Boer |Anna Maria
Docherty, K. F. et al. (2024) Wearable accelerometer-derived measures of physical activity in heart failure: insights from the DETERMINE trials. Journal of Cardiac Failure, (Accepted for Publication)Text339510.pdf - Accepted Version Restricted to Repository staff only734kBItem Type:ArticlesAdditional Information:The DETERMINE trials were sponsored by AstraZeneca. Professor McMurray is supported by a British Heart Foundation Centre of Research Excellence Grant RE/18/6/34217.
-
Sep 19, 2024 | 
eprints.gla.ac.uk | De Boer |Carolyn S.P |John J.V
Pabon, M. A. et al. (2024) In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3410) (PMID:39300780) (Early Online Publication)Text336363.pdf - Published Version Available under License Creative Commons Attribution Non-commercial.
-
Aug 31, 2024 | 
eprints.gla.ac.uk | De Boer |Carolyn S.P |van Veldhuisen |John J.V
Matsumoto, S. et al. (2024) Beta‐blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Journal of Heart Failure, (doi: 10.1002/ejhf.3383) (PMID:39215677) (Early Online Publication)Full text not currently available from Enlighten.
-
Aug 28, 2024 | 
eprints.gla.ac.uk | De Boer |Anna Maria |John J.V |Ruben Buendia
Docherty, K. F. et al. (2024) The effect of dapagliflozin on accelerometer-based measures of physical activity in patients with heart failure: an analysis of the DETERMINE trials. Circulation: Heart Failure, (Accepted for Publication)Text333665.pdf - Accepted Version Restricted to Repository staff only704kBItem Type:ArticlesAdditional Information:Funding: The DETERMINE trials were sponsored by AstraZeneca.
-
Aug 21, 2024 | 
eprints.gla.ac.uk | De Boer |Carolyn S.P |Kerr Saraiva |John J.V
Yang, M. et al. (2024) Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment. European Journal of Heart Failure, (doi: 10.1002/ejhf.3417) (PMID:39169481) (Early Online Publication)Full text not currently available from Enlighten. AbstractAims:Although the prevalence of heart failure (HF) increases markedly with advancing age, surprisingly little is known about HF in the very elderly.
